Background: Cancer is a leading cause of death worldwide as well as in Peru. The national cancer plan includes decentralization, but one of the greatest barriers is our complicated geography. San Martin is a department located in the Peruvian jungle where there are no public services for cancer care. Our aim was to implement a "distance telemedicine-enabled" outpatient chemotherapy module, monitored by oncologists. Methods: The implementation was conducted in 3 stages: 1) Planning and Organization: working teams were formed, a chemotherapy room was developed and people were trained. 2) Execution: patients from San Martín region, aged >18 years with pathological confirmation of cancer, requiring systemic chemotherapy, ECOG <3, and first course of chemotherapy received at INEN without adverse reaction were selected. 3) Evaluation: adverse events, cost-user evaluation and quality of life (QoL) were assessed. Results: By November 2015, a module with a chemotherapy room with 18 chairs, a pharmacy, a hospitalization room, 1 medical office, a training room, a nutrition area, and a nursing station was implemented. 3 physicians, 3 nurses and 1 pharmacist were trained. Through March 2018, 501 sessions of teleoncology were completed to deliver 232 cycles of chemotherapy for 56 patients aged 19 -78 years with different solid tumors, with no serious adverse event, without negatively affecting their QoL, and with an average out-of-pocket expense saving of 500 PEN. Conclusions: Using information and communication technology, a telechemotherapy module was successfully implemented in the Peruvian jungle, without adversely affecting the QoL of patients. Neither patients nor family members needed to travel to Lima to receive chemotherapy. This first program can be replicated in other rural and remote regions through non-specialized personnel and facilities, providing chemotherapy services equivalent to a tertiary center through trained health care professionals, supported through telemedicine.
Introduction
Cancer is the second leading cause of death worldwide and was responsible for 8.8 million deaths in 2015. Approximately 70% of deaths occur in low and middle-income countries [1] . More than 90% of high-income countries report having comparable treatment services available to less than 30% of low-income countries [1] . According to Globocan 2012 , in Peru, the most prevalent cancers are cervical, gastric, breast, prostate and colorectal cancer [2] .
Telemedicine applied to teleoncology began with the use of videoconferencing in the evaluation of the care of cancer patients and goes back to 1990 [3] . Subsequently, cancer patient's satisfaction regarding teleoncology has been evaluated in a rural area [4] , for medical evaluation and tumor clinical-pathology consultation [5] [6] [7] , and to prospectively evaluate the feasibility of administering chemotherapy in rural and remote areas [8] [9] [10] .
INEN (The Instituto Nacional de Enfermedades Neoplásicas) launched "Plan
Esperanza" in 2012 to improve population-based cancer control outcomes through decentralization of oncological services, along with strategies that bring quality services closer to the patients' home and community [11] . 75% of the cases referred to (INEN) are in advanced stages [12] and require systemic treatment (chemotherapy). In the Department of San Martín in the Peruvian jungle, cancer care is not provided in public health centers. Accordingly, an initiative to provide chemotherapy through a satellite module (telechemotherapy) was undertaken in the remote region of Lamas in the Peruvian Amazon.
Geographic barriers to access to oncological services and more specifically to administration of chemotherapy exist. This report addresses the implementation of a "distance telemedicine-enabled" outpatient chemotherapy module, monitored by INEN oncologists, in a non-specialized hospital in the Peruvian jungle, to determine whether the quality of life and costs of care were impacted by delivering care "closer to home". The implementation of the National Cancer Plan for Peru (Plan Esperanza), has been essential to bring cancer care to rural and remote communities. With the implementation of the telechemotherapy module (TELECHEMO) and the administration of systemic chemotherapy, the quality of life, social and economic implications of delivering care closer to home were investigated.
Materials and Methods

Implementation of the telechemoterapy module
The Lamas Hospital, category II-E (second level of care), located in the Peruvian jungle, was selected for the implementation of TELECHEMO. The hospital has two pathologists, and no medical or radiation oncologists. The development process included 3 stages: 1) planning and organization, 2) execution or implementation and 3) monitoring and evaluation, each requiring several phases ( Figure 1 ).
Planning and Organization
Four phases were addressed from December 2014 to November 2015. 
Execution
Monitoring and Evaluation
Patients, Chemotherapy and Type of Cancer
Cost-User Evaluation
For the cost-user evaluation, a survey to assess the time it took patients on average to travel from their home to the chemotherapy room while in Lima or Lamas was taken. Additionally, a cost survey captured the experiences, food, lodging, transportation from home to the hospital in both Lima (INEN) and the Lamas Hospital. 
Assessment of Quality of Life
Ethical considerations
The project was approved by the Ethics Committee of INEN. All patients entering the program signed informed consent.
Results
Implementation Indicators
Infrastructure
The module consists of a chemotherapy area with 18 chairs, a pharmacy area including drug preparation and handling, a hospitalization room, 1 office, a training room, a nutrition area, a nursing station and a waiting room.
Training for health personnel
During the implementation process, health professionals were trained for three months: two Lamas Hospital II general practitioners were trained in the evaluation of cancer patients in outpatient, in inpatient, emergency and ambulatory chemotherapy room practice. Three nurses were trained in verification, Journal of Cancer Therapy administration and monitoring of chemotherapy, and in palliative care for terminally ill patients. One pharmacist was trained in the preparation, dispensing and distribution of chemotherapy.
Process Indicators
The number of patients admitted to the TELECHEMO module, the number of chemotherapy cycles, the number of sessions for administration of chemotherapy, and complications secondary to treatment were recorded.
Patients admitted to the TELECHEMO module From November 2015 to March 2018, 121 patients met the inclusion and exclusion criteria and 56 patients (46.3%) were enrolled in the program. The clinical-pathological characteristics of the 56 patients are shown in Table 1 . The median age was 56 years, most were women, predominantly with advanced stages of disease. Chemotherapy was initiated at INEN and continued within the local social and family environment without alteration, according to the standards of administration of ambulatory chemotherapy at INEN i.e. supply of medicines, preparation of medicines in laminar flow hood by pharmacists with training in chemotherapy preparation, administration of chemotherapy and medical monitoring by trained nurses. 
Medical evaluation of enrolled patients (Teleconsultation)
The medical teams at Lamas hospital and INEN held medical evaluation meetings before each cycle of chemotherapy (n = 232), and 215 medical consultations Indirect costs for comprehensive oncological care ( Table 3) A survey of indirect costs related to the entire care process was conducted. 
Cost/User Indicators
Quality Indicator
Quality of life (QoL) (Figures 2-4 )
Results of a pilot study of QoL on patients enrolled in the first two months are shown in Figure 2 to Figure 4 . Improvement in perceived global health status/ quality of life ( Figure 2 ), and improvement in the different spheres of functional performance, particularly social and emotional well-being (Figure 3) were noted. Symptoms tended to decrease with time, consistent with improved control of disease with chemotherapy, with patients reporting a marked decrease in perceived economic difficulties over the 3-month treatment period (Figure 4 ). 
Discussion
This study reports the first documented experience in Latin America with the use of teleoncology to facilitate access to a highly complex cancer treatment (chemotherapy) in a remote and rural area, with improved quality of life and reduced financial and time burden for the patient.
Plan Esperanza, (the National Cancer Control Plan for Peru), has promulgated implementation strategies bringing oncology services to the most remote areas of the country according to standards similar to the comprehensive cancer care provided by INEN, through a collaborative alliance between institutions at the central and regional levels [10] . Peru is promoting the National Telehealth
Network of the Ministry of Health (MINSA) in 118 hospitals nationwide to support remote medical care [16] . The technical standards for telehealth in Peru were published in 2009, with the first initiative being the provision of highly specialized remote care through teleoncology with the TELECHEMO module in
Lamas [17] .
The implementation of telemedicine in oncology has been carried out with great success in Australia, since 2012, with chemotherapy being administered in 6 rural medical centers aligned with the Cancer Center of Townsville in Queensland [18] [19] . The extended face-to-face visit complemented by teleoncology for consultations and supervision of chemotherapy administration [20] was ap-Journal of Cancer Therapy plied in Lamas, similar to the practice in Australian centers. Sabesan (2012) reported the use of telechemotherapy in 158 patients with solid tumors, mainly breast cancer [18] . 69% of the patients with a median age 64 years) were treated with palliative intent; most had advanced cancer, all had solid tumors, with breast cancer being the most frequent, and 89% (median age 48 years) received chemotherapy with palliative intent. Chan (2015) noted no difference in tolerance comparing 89 patients receiving chemotherapy in the rural area of Mount Isa with 117 patients treated at the central hospital in Townsville [19] . The same group had shown previously that the administration of intense chemotherapy (doxorubicin-cyclophosphamide (AC), capecitabine-oxaliplatin (CAPOX)) in rural areas was safe and well-tolerated, with only 2 patients requiring central hospitalization [21] . Quality of life is commonly evaluated in clinical trials, but less frequently in Journal of Cancer Therapy retrospective studies. The EORTC QLQ-C30 version 3 has been validated in patients with prostate cancer with radiotherapy and/or hormonotherapy but not with chemotherapy [15] . For patients with early and locally advanced stages of breast cancer undergoing surgery, and radiotherapy or chemotherapy, better quality of life was reported in patients with early cancer [14] . 
Limitations
The present study has limitations due to a low number of patients included, the lack of sub classification of each type of cancer, the staging in early or advanced diseases and grouping according to age in young and older patients, and technical issues e.g. internet connection problems requiring cell phones to be used to communicate. It was impossible to determine the cost savings for companions when they did not interrupt their daily work activity due to the patient receiving treatment in Lamas.
In conclusion, using information and communication technology, a telechemotherapy module was successfully implemented in the Peruvian jungle, without adversely affecting the quality of life of patients. Neither patients nor family members needed to travel to Lima to receive their treatments, thereby avoiding travel, hospitality and food costs. This first program can be replicated in other rural and remote regions through non-specialized personnel and facilities, providing chemotherapy services equivalent to a tertiary center through trained health care professionals, supported, supervised and monitored through telemedicine.
